According to a recent LinkedIn post from Doccla, the company is involved in delivering a home-based end-of-life monitoring programme called the Comfort Tracker in partnership with clinical co-creators and U.K. National Health Service providers. The tool is described as enabling patients and carers to report symptoms, comfort levels, and concerns from home, addressing preferences for home-based end-of-life care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post indicates that the programme is already live across Sussex Community NHS Foundation Trust and East Sussex Healthcare NHS Trust, with more than 200 patients supported so far and a rollout to 1,000 patients planned over the next 12 months. For investors, this suggests growing adoption of Doccla’s remote monitoring capabilities in the U.K. public health system, potentially reinforcing its positioning in community and end-of-life care and supporting future revenue opportunities linked to broader NHS or international deployments.